Tao Lu

3.1k total citations
116 papers, 2.4k citations indexed

About

Tao Lu is a scholar working on Molecular Biology, Oncology and Computational Theory and Mathematics. According to data from OpenAlex, Tao Lu has authored 116 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 32 papers in Oncology and 20 papers in Computational Theory and Mathematics. Recurrent topics in Tao Lu's work include Computational Drug Discovery Methods (20 papers), Cancer-related Molecular Pathways (10 papers) and Protein Degradation and Inhibitors (10 papers). Tao Lu is often cited by papers focused on Computational Drug Discovery Methods (20 papers), Cancer-related Molecular Pathways (10 papers) and Protein Degradation and Inhibitors (10 papers). Tao Lu collaborates with scholars based in China, United States and United Kingdom. Tao Lu's co-authors include Yadong Chen, Xuanyong Liu, Congqin Ning, Paul K. Chu, Hongmei Li, Shuai Lü, Honglu Wu, Jin Wen, Ye Zhang and Rong Fu and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Biomaterials.

In The Last Decade

Tao Lu

111 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tao Lu China	25	1.0k	479	426	357	297	116	2.4k
Manash K. Paul United States	26	1.3k 1.3×	477 1.0×	715 1.7×	163 0.5×	261 0.9×	72	3.0k
Tianqi Wang China	16	876 0.8×	175 0.4×	434 1.0×	238 0.7×	128 0.4×	70	1.8k
Ana Bela Sarmento‐Ribeiro Portugal	30	1.5k 1.5×	357 0.7×	729 1.7×	140 0.4×	148 0.5×	130	3.2k
Kun Peng China	26	967 0.9×	214 0.4×	196 0.5×	82 0.2×	403 1.4×	84	2.5k
Jong K. Yun United States	29	2.2k 2.1×	221 0.5×	182 0.4×	175 0.5×	166 0.6×	62	3.2k
Hao Xiong United States	29	2.0k 1.9×	300 0.6×	1.6k 3.8×	97 0.3×	325 1.1×	132	4.4k
Shili Xu United States	25	1.1k 1.1×	196 0.4×	639 1.5×	190 0.5×	130 0.4×	61	2.4k
Ran Tian China	24	1.0k 1.0×	460 1.0×	320 0.8×	117 0.3×	108 0.4×	40	1.9k
Anthony M. Davies Ireland	25	871 0.8×	572 1.2×	381 0.9×	87 0.2×	127 0.4×	51	2.3k
Peipei Xu China	24	800 0.8×	576 1.2×	339 0.8×	110 0.3×	222 0.7×	159	2.2k

Countries citing papers authored by Tao Lu

Since Specialization

Citations

This map shows the geographic impact of Tao Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Lu more than expected).

Fields of papers citing papers by Tao Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tao Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Lu. The network helps show where Tao Lu may publish in the future.

Co-authorship network of co-authors of Tao Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Tao Lu. A scholar is included among the top collaborators of Tao Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tao Lu. Tao Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dong, Wen‐Fei, Jie Liu, Tao Lu, et al.. (2025). A novel detection mode for ascorbic acid with high selectivity based on peroxidase mimetic system. Microchemical Journal. 209. 112753–112753. 1 indexed citations

Bai, Shanshan, Tiantian Huang, Tao Lu, et al.. (2025). Therapeutic potential of luteolin in central precocious puberty: insights from a danazol-induced rat model. Frontiers in Endocrinology. 16. 1666932–1666932.

Yang, Mengyu, Hongmei Li, Tao Lu, et al.. (2024). Design, Synthesis, and Biological Evaluation of a Novel NIK Inhibitor with Anti-Inflammatory and Hepatoprotective Effects for Sepsis Treatment. Journal of Medicinal Chemistry. 67(7). 5617–5641. 7 indexed citations

Lu, Tao, et al.. (2024). ScribSD+: Scribble-supervised medical image segmentation based on simultaneous multi-scale knowledge distillation and class-wise contrastive regularization. Computerized Medical Imaging and Graphics. 116. 102416–102416. 2 indexed citations

Li, Yang, Lei Di, Li‐Juan Liu, et al.. (2024). A naturally derived small molecule compound suppresses tumor growth and metastasis in mice by relieving p53-dependent repression of CDK2/Rb signaling and the Snail-driven EMT. Chinese Journal of Natural Medicines. 22(2). 112–126. 2 indexed citations

Cui, Bingbing, Yong Wang, Fan Lü, et al.. (2023). Discovery of 3-(1H-benzo[d]imidazole-2-yl)-1H-pyrazol-4 -amine derivatives as novel and potent syk inhibitors for the treatment of hematological malignancies. European Journal of Medicinal Chemistry. 258. 115597–115597. 7 indexed citations

Wang, Qi, et al.. (2023). The effect of cerebral blood perfusion on the correlation between cerebral stroke onset time and synthetic T2 mapping: a pilot study. Quantitative Imaging in Medicine and Surgery. 13(6). 3477–3488. 4 indexed citations

Berdecka, Dominika, Tao Lu, Deep Punj, et al.. (2023). Photothermal nanofibers enable macromolecule delivery in unstimulated human T cells. Applied Materials Today. 35. 101991–101991. 5 indexed citations

Tian, Wen, et al.. (2023). Review and prospects of targeted therapies for Spleen tyrosine kinase (SYK). Bioorganic & Medicinal Chemistry. 96. 117514–117514. 8 indexed citations

10.

Ran, Ting, Peng Qi, Tao Lu, et al.. (2023). Development of 3-acetylindole derivatives that selectively target BRPF1 as new inhibitors of receptor activator of NF-κB ligand (RANKL)-Induced osteoclastogenesis. Bioorganic & Medicinal Chemistry. 96. 117440–117440. 2 indexed citations

11.

Huang, Jianhang, Xiaoyue Liu, Hongmei Li, et al.. (2021). Discovery of N-(4-(3-isopropyl-2-methyl-2H-indazol-5-yl)pyrimidin-2-yl)-4-(4-methylpiperazin-1-yl)quinazolin-7-amine as a Novel, Potent, and Oral Cyclin-Dependent Kinase Inhibitor against Haematological Malignancies. Journal of Medicinal Chemistry. 64(17). 12548–12571. 12 indexed citations

12.

Cui, Hao, Lei Yan, Jiaqi Niu, et al.. (2021). Design and synthesis of dual inhibitors targeting snail and histone deacetylase for the treatment of solid tumour cancer. European Journal of Medicinal Chemistry. 229. 114082–114082. 16 indexed citations

13.

Cheng, Jie, et al.. (2021). FLT3 Inhibitors in Acute Myeloid Leukemia: Challenges and Recent Developments in Overcoming Resistance. Journal of Medicinal Chemistry. 64(6). 2878–2900. 67 indexed citations

14.

Chen, Yun, Yingli Wu, Jie Cheng, et al.. (2021). Discovery of a Potent FLT3 Inhibitor (LT-850-166) with the Capacity of Overcoming a Variety of FLT3 Mutations. Journal of Medicinal Chemistry. 64(19). 14664–14701. 22 indexed citations

15.

Li, Hongmei, Li Yang, Rong Fu, et al.. (2020). A potent CBP/p300-Snail interaction inhibitor suppresses tumor growth and metastasis in wild-type p53-expressing cancer. Science Advances. 6(17). eaaw8500–eaaw8500. 40 indexed citations

16.

Zhang, Yanmin, Yi Hua, Yuchen Wang, et al.. (2019). Investigation of Machine Intelligence in Compound Cell Activity Classification. Molecular Pharmaceutics. 16(11). 4472–4484. 7 indexed citations

17.

Wang, Zhijie, Hongmei Li, Liang Zhang, et al.. (2019). Combining structure- and property-based optimization to identify selective FLT3-ITD inhibitors with good antitumor efficacy in AML cell inoculated mouse xenograft model. European Journal of Medicinal Chemistry. 176. 248–267. 13 indexed citations

18.

Zhi, Yanle, Haoliang Yuan, Zhijie Wang, et al.. (2018). Discovery of a highly selective FLT3 inhibitor with specific proliferation inhibition against AML cells harboring FLT3-ITD mutation. European Journal of Medicinal Chemistry. 163. 195–206. 18 indexed citations

19.

Wang, Yue, Yanle Zhi, Qiaomei Jin, et al.. (2018). Discovery of 4-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrazole-3-carboxamide (FN-1501), an FLT3- and CDK-Kinase Inhibitor with Potentially High Efficiency against Acute Myelocytic Leukemia. Journal of Medicinal Chemistry. 61(4). 1499–1518. 89 indexed citations

20.

Wang, Jinglin, Hailin Zhang, Jihua Zhou, et al.. (2010). First detection of Tuala-like Hantanvirus from Eothenomys milelus in China.. Zhongguo renshougonghuanbing zazhi. 26(5). 408–412. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact